Improvement of RBD-FC Immunogenicity by Using Alum-Sodium Alginate Adjuvant Against SARS-COV-2

被引:1
|
作者
Dehghan, Mahboobeh [1 ]
Askari, Hossein [1 ]
Tohidfar, Masoud [1 ]
Siadat, Seyed Omid Ranaei [2 ]
Fatemi, Fataneh [2 ]
机构
[1] Shahid Beheshti Univ, Fac Life Sci & Biotechnol, Dept Cellular & Mol Biol, Tehran, Iran
[2] Shahid Beheshti Univ, Prot Res Ctr, Tehran, Iran
关键词
aluminum hydroxide; cytokine; immunogenicity; RBD-FC; SARS-CoV-2; sodium alginate; vaccine; RECEPTOR-BINDING DOMAIN; SPIKE PROTEIN; VACCINE ADJUVANTS; DELIVERY-SYSTEMS; CHITOSAN; CORONAVIRUSES; ANTIBODIES;
D O I
10.1111/irv.70018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundAdjuvants use several mechanisms to boost immunogenicity and to modulate immune response. The strength of adsorption of antigen by adjuvants can be a determinant factor for significant improvement of immunopotentiation.MethodsWe expressed recombinant RBD-FC in PichiaPink Strain 4 and examined the vaccination of mice by vaccine formulation with different adjuvants (sodium alginate and aluminum hydroxide, alone and together).ResultsSodium alginate significantly increased the immunogenicity and stability of RBD-FC antigen, so RBD-FC formulated with combined alginate and alum (AlSa) and sodium alginate alone showed higher antibody titer and stability. Immunogenicity of RBD-FC:AlSa was determined by serological assays including direct enzyme-linked immunosorbent assay (ELISA) and surrogate virus neutralization test (sVNT). High levels of IgGs and neutralizing antibodies were measured in serum of mice immunized with the RBD-FC:AlSa formulation. On the other hand, cytokines IL-10 and INF-gamma were severely accumulated in response to RBD-FC:AlSa, and after 10 days, their accumulation was significantly declined, whereas IL-4 showed the highest and the lowest accumulation in response to alum and alginate, respectively.ConclusionsOur data may suggest that combination of alum and sodium alginate has a better compatibility with RBD-FC in vaccine formulation.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity
    Zheng, Xiaotong
    Yang, Rong
    Zhao, Yuxiu
    Zhang, Yadan
    Yuan, Guangying
    Li, Weidong
    Xiao, Zhuangzhuang
    Dong, Xiaofei
    Ma, Meng
    Guo, Yancen
    Wang, Wei
    Zhao, Xue
    Yang, Hongqiang
    Qiu, Shaoting
    Peng, Zheng
    Liu, Ankang
    Yu, Shouzhi
    Zhang, Yuntao
    VIROLOGY, 2024, 594
  • [32] Immunogenicity Evaluation of a SARS-CoV-2 BA.2 Subunit Vaccine Formulated with CpG 1826 plus alum Dual Adjuvant
    Yuhan Yan
    Qiudong Su
    Yao Yi
    Liping Shen
    Shengli Bi
    Biomedical and Environmental Sciences, 2024, 37 (12) : 1409 - 1420
  • [33] Immunogenicity Evaluation of a SARS-CoV-2 BA.2 Subunit Vaccine Formulated with CpG 1826 plus alum Dual Adjuvant
    Yan, Yuhan
    Su, Qiudong
    Yi, Yao
    Shen, Liping
    Bi, Shengli
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2024, 37 (12) : 1409 - 1420
  • [34] Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
    David G. Alleva
    Eline A. Feitsma
    Yester F. Janssen
    Hendrikus H. Boersma
    Thomas M. Lancaster
    Thillainaygam Sathiyaseelan
    Sylaja Murikipudi
    Andrea R. Delpero
    Melanie M. Scully
    Ramya Ragupathy
    Sravya Kotha
    Jeffrey R. Haworth
    Nishit J. Shah
    Vidhya Rao
    Shashikant Nagre
    Shannon E. Ronca
    Freedom M. Green
    Stephen A. Shaw
    Ari Aminetzah
    Schelto Kruijff
    Maarten Brom
    Gooitzen M. van Dam
    Todd C. Zion
    npj Vaccines, 9
  • [35] Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
    Alleva, David G.
    Feitsma, Eline A.
    Janssen, Yester F.
    Boersma, Hendrikus H.
    Lancaster, Thomas M.
    Sathiyaseelan, Thillainaygam
    Murikipudi, Sylaja
    Delpero, Andrea R.
    Scully, Melanie M.
    Ragupathy, Ramya
    Kotha, Sravya
    Haworth, Jeffrey R.
    Shah, Nishit J.
    Rao, Vidhya
    Nagre, Shashikant
    Ronca, Shannon E.
    Green, Freedom M.
    Shaw, Stephen A.
    Aminetzah, Ari
    Kruijff, Schelto
    Brom, Maarten
    van Dam, Gooitzen M.
    Zion, Todd C.
    NPJ VACCINES, 2024, 9 (01)
  • [36] Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 (vol 31, pg 1011, 2021)
    Sun, Shiyu
    Cai, Yueqi
    Song, Tian-Zhang
    Pu, Yang
    Cheng, Lin
    Xu, Hairong
    Sun, Jing
    Meng, Chaoyang
    Lin, Yifan
    Huang, Haibin
    Zhao, Fang
    Zhang, Silin
    Gao, Yu
    Han, Jian-Bao
    Feng, Xiao-Li
    Yu, Dan-Dan
    Zhu, Yalan
    Gao, Pu
    Tang, Haidong
    Zhao, Jincun
    Zhang, Zheng
    Yang, Jiaming
    Hu, Zhenxiang
    Fu, Yang-Xin
    Zheng, Yong-Tang
    Peng, Hua
    CELL RESEARCH, 2021, 31 (11) : 1222 - 1222
  • [37] Screening and optimization of shark nanobodies against SARS-CoV-2 spike RBD
    Liu, Xiaochun
    Wang, Yanqing
    Sun, Lishan
    Xiao, Guokai
    Hou, Ning
    Chen, Jin
    Wang, Wei
    Xu, Ximing
    Gu, Yuchao
    ANTIVIRAL RESEARCH, 2024, 226
  • [38] SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
    Routhu, Nanda Kishore
    Cheedarla, Narayanaiah
    Bollimpelli, Venkata Satish
    Gangadhara, Sailaja
    Edara, Venkata Viswanadh
    Lai, Lilin
    Sahoo, Anusmita
    Shiferaw, Ayalnesh
    Styles, Tiffany M.
    Floyd, Katharine
    Fischinger, Stephanie
    Atyeo, Caroline
    Shin, Sally A.
    Gumber, Sanjeev
    Kirejczyk, Shannon
    Dinnon, Kenneth H.
    Shi, Pei-Yong
    Menachery, Vineet D.
    Tomai, Mark
    Fox, Christopher B.
    Alter, Galit
    Vanderford, Thomas H.
    Gralinski, Lisa
    Suthar, Mehul S.
    Amara, Rama Rao
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [39] SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
    Nanda Kishore Routhu
    Narayanaiah Cheedarla
    Venkata Satish Bollimpelli
    Sailaja Gangadhara
    Venkata Viswanadh Edara
    Lilin Lai
    Anusmita Sahoo
    Ayalnesh Shiferaw
    Tiffany M. Styles
    Katharine Floyd
    Stephanie Fischinger
    Caroline Atyeo
    Sally A. Shin
    Sanjeev Gumber
    Shannon Kirejczyk
    Kenneth H. Dinnon
    Pei-Yong Shi
    Vineet D. Menachery
    Mark Tomai
    Christopher B. Fox
    Galit Alter
    Thomas H. Vanderford
    Lisa Gralinski
    Mehul S. Suthar
    Rama Rao Amara
    Nature Communications, 12
  • [40] Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein
    de Oliveira Silva, Mariangela
    Castro-Amarante, Maria Fernanda
    Venceslau-Carvalho, Alexia Adrianne
    da Silva Almeida, Bianca
    Daher, Isabela Pazotti
    de Souza-Silva, Guilherme Antonio
    Yamamoto, Marcio Massao
    Koike, Gabriela
    de Souza, Edmarcia Elisa
    Wrenger, Carsten
    de Souza Ferreira, Luis Carlos
    Boscardin, Silvia Beatriz
    VACCINES, 2024, 12 (04)